Dalian BIO-CHEM Company Limited (SHA:603360)
China flag China · Delayed Price · Currency is CNY
10.11
-0.37 (-3.53%)
Nov 6, 2026, 3:00 PM CST

Dalian BIO-CHEM Company Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
151.79209.77391.76328.38402.57250.49
Depreciation & Amortization
97.8998.1769.7264.0471.0148.22
Other Amortization
7.327.040.4-0.511.1
Loss (Gain) From Sale of Assets
-0.17-0.17---0.07-
Asset Writedown & Restructuring Costs
0.060.060.260.110.260.97
Loss (Gain) From Sale of Investments
-0.4-0.4-68.81-0.357.57-0.59
Provision & Write-off of Bad Debts
-7.24-7.247.24-1.430.834.1
Other Operating Activities
-91.59126.1223.5717.110.811.66
Change in Accounts Receivable
241.76241.76-263.47-9.4843.07-120.15
Change in Inventory
-120.47-120.47-48.82-25.96.58-81.45
Change in Accounts Payable
-4.25-4.2547.96.71-73.081.29
Change in Other Net Operating Assets
16.982.080.1315.478.47-
Operating Cash Flow
285.9546.69162.98389.69479.9142.03
Operating Cash Flow Growth
132.75%235.44%-58.18%-18.80%237.90%-32.57%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-118.37-36.67-74.91-67.35-134.28-191.61
Sale of Property, Plant & Equipment
0.230.30.080.100.02
Divestitures
--31.03-12.25-
Investment in Securities
1.4-153.2--60-140
Other Investing Activities
248.29147.76158.170.33-2.571.19
Investing Cash Flow
131.59-41.81114.36-126.92-124.61-50.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----99398.49
Long-Term Debt Issued
-1,314355149.97--
Total Debt Issued
801.61,314355149.9799398.49
Short-Term Debt Repaid
-----337.99-261.28
Long-Term Debt Repaid
--590-270.9-129.43--
Lease Payments
-2.03-2.03-5.91-0.43--
Total Debt Repaid
-649.81-590-270.9-129.43-337.99-261.28
Net Debt Issued (Repaid)
151.79723.8584.120.54-238.99137.2
Issuance of Common Stock
2.982.98-27.773.7536.92
Repurchase of Common Stock
-400.02-400.02----45.11
Common Dividends Paid
-34-331.55-223.62-206.86-6.5-159.02
Other Financing Activities
41.33-7.6249.36-29.670.87-28.65
Financing Cash Flow
-237.92-12.36-90.17-188.16-170.86-58.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.52-1.497.693.4-0.2-0.53
Net Cash Flow
172.05491.04194.8678.01184.2332.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
167.53510.0388.07322.33345.62-49.58
Free Cash Flow Growth
163.73%479.14%-72.68%-6.74%--
Free Cash Flow Margin
11.65%29.59%6.93%30.25%27.50%-4.93%
Free Cash Flow Per Share
0.230.730.130.460.50-0.07
Levered Free Cash Flow
114.08433.09-386.32217.25-64.01-15.74
Unlevered Free Cash Flow
119.52452.01-382.13219.7-61.69-8.39
Free Cash Flow After Leases
165.550882.15321.9345.62-49.58

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.98
Cash Income Tax Paid
36.8358.4161.4436.4144.7737.56
Change in Working Capital
128.23113.33-261.17-18.18-3.56-173.93